Funding Rounds
Adrenomed

Adrenomed Series E round, November 2020

Adrenomed

Adrenomed is a sepsis drug.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series E

Raised Amount: $26.30M

Raised Date: 2020-11-30